Final results of an international three-arm randomised phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer (NorCap-CA223 trial)

Cinieri S., Chan A., Altundag K., Tubiana-Mathieu N., Barnadas A., Dodyk P., ...Daha Fazla

European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49 identifier

  • Cilt numarası: 49
  • Basıldığı Şehir: Amsterdam
  • Basıldığı Ülke: Hollanda